Li, Mengru
Zhang, Yi
Chen, Xiaotian
Wang, Dingmei
Ji, Mi
Jiang, Yuan
Dou, Yalan
Ma, Xiaojing
Sheng, Wei
Yan, Weili
Huang, Guoying
Funding for this research was provided by:
National Key Research and Development Program of China (2016YFC1000506)
Article History
Received: 26 February 2020
Accepted: 4 August 2020
First Online: 20 August 2020
Ethics approval and consent to participate
: The trial protocol received ethical approval from the Ethics board of Children’s Hospital clinical pharmacology IRB of Fudan University (Approval Number: 2018–151, approval date: Jun 20, 2018). Then written informed consent will be obtained from all participates who will be informed that they could cancel their consent at any time, without harming the care provided in the health centers.
: Not applicable.
: The authors declare that they have no competing interests.